European Journal of Haematology

Cover image for Vol. 93 Issue 3

Accepted Articles (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)

Edited By: Karl-Anton Kreuzer

Impact Factor: 2.414

ISI Journal Citation Reports © Ranking: 2013: 36/68 (Hematology)

Online ISSN: 1600-0609


  1. 1 - 27
  1. Original Articles

    1. The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma.

      Zhen Ying Gan, Stephen Fitter, Kate Vandyke, Luen B. To, Andrew C.W. Zannettino and Sally K. Martin

      Accepted manuscript online: 2 SEP 2014 12:30AM EST | DOI: 10.1111/ejh.12436

  2. Review Articles

    1. You have free access to this content
      Role of Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma

      Jonathon B. Cohen, Linda J. Burns and Veronika Bachanova

      Accepted manuscript online: 23 AUG 2014 08:59AM EST | DOI: 10.1111/ejh.12442

  3. Review articles

    1. You have free access to this content
      Gamma-delta t-cell lymphomas

      Marco Foppoli and Andrés J. M. Ferreri

      Accepted manuscript online: 23 AUG 2014 08:59AM EST | DOI: 10.1111/ejh.12439

  4. Original Articles

    1. TP53 mutations and Mdm2SNP309 identify subgroups of AML patients with impaired outcome

      Ingrid Jakobsen Falk, Kerstin Willander, Roza Chaireti, Johan Lund, Hareth Nahi, Monica Hermanson, Henrik Gréen, Kourosh Lotfi and Peter Söderkvist

      Accepted manuscript online: 23 AUG 2014 08:59AM EST | DOI: 10.1111/ejh.12438

    2. Deferasirox For Iron Chelation In Multi-Transfused Children With Sickle Cell Disease; Long-Term Experience In The East London Clinical Haemoglobinopathy Network

      E Tsouana, B Kaya, N Gadong, C Hemmaway, H Newell, A Simmons, S Whitmarsh and P Telfer

      Accepted manuscript online: 19 AUG 2014 05:55AM EST | DOI: 10.1111/ejh.12435

    3. LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens

      CS Chim, Joycelyn Sim, Sidney Tam, Eric Tse, AKW Lie and YL Kwong

      Accepted manuscript online: 18 AUG 2014 10:46AM EST | DOI: 10.1111/ejh.12434

  5. Review Articles

    1. You have full text access to this OnlineOpen article
      Switching treatments in haemophilia: is there a risk of inhibitor development?

      Elena Santagostino, Günter Auerswald, Gary Benson, Gerry Dolan, Victor Jiménez-Yuste, Thierry Lambert, Rolf Ljung, Massimo Morfini, Eduardo Remor and Silva Zupančić Šalek

      Accepted manuscript online: 18 AUG 2014 10:46AM EST | DOI: 10.1111/ejh.12433

  6. Original Articles

    1. Validation of diagnosis of aplastic anaemia in La Rioja (Spain) by International Classification of Diseases codes for case ascertainment for the Spanish National Rare Diseases Registry

      Elena Ruiz, Enrique Ramalle-Gómara, Carmen Quiñones, Pilar Rabasa and Carlos Pisón

      Accepted manuscript online: 18 AUG 2014 10:46AM EST | DOI: 10.1111/ejh.12432

    2. Co-inheritance of the rare β hemoglobin variants Hb Yaounde, Hb Görwihl and Hb City of Hope with other alterations in globin genes: impact in genetic counseling.

      Margherita Vinciguerra, Cristina Passarello, Filippo Leto, Filippo Cassarà, Monica Cannata, Aurelio Maggio and Antonino Giambona

      Accepted manuscript online: 12 AUG 2014 03:56AM EST | DOI: 10.1111/ejh.12431

    3. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)

      Thierry Guillaume, Yves Beguin, Reza Tabrizi, Stéphanie Nguyen, Didier Blaise, Eric Deconinck, Rabah Redjoul, Jérôme Cornillon, Gaëlle Guillerm, Nathalie Contentin, Anne Sirvent, Pascal Turlure, Alexandra Salmon, Anne Huynh, Sylvie François, Régis Peffault de Latour, Ibrahim Yakoub-Agha and Mohamad Mohty

      Accepted manuscript online: 11 AUG 2014 04:38AM EST | DOI: 10.1111/ejh.12430

  7. Letter to the Editor

    1. Low-dose chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab in follicular lymphoma

      Emanuele Cencini, Alberto Fabbri, Luana Schiattone, Giulia Bartalucci and Monica Bocchia

      Accepted manuscript online: 1 AUG 2014 02:23AM EST | DOI: 10.1111/ejh.12428

  8. Review Articles

    1. You have free access to this content
      B cell receptor (BCR) signalling and its crosstalk with other pathways in normal and malignant cells

      Vaclav Seda and Marek Mraz

      Accepted manuscript online: 1 AUG 2014 02:23AM EST | DOI: 10.1111/ejh.12427

  9. Case Reports

    1. A novel large deletion and single nucleotide insertion in the Wiskott-Aldrich syndrome protein gene

      Vera Gulácsy, Beáta Soltész, Carmen Petrescu, Mihaela Bataneant, Edit Gyimesi, Margit Serban, László Maródi and Beáta Tóth

      Accepted manuscript online: 1 AUG 2014 02:23AM EST | DOI: 10.1111/ejh.12424

  10. Original Articles

    1. Hematopoietic clonal dominance, stem cell mutations and evolutionary pattern of jak2v617f allele burden in polycythemia vera

      Anna Angona, Alberto Alvarez-Larrán, Beatriz Bellosillo, Luz Martínez-Avilés, Laura Camacho, M. Concepción Fernández-Rodríguez, Silvia Pairet, Raquel Longarón, Águeda Ancochea, Alicia Senín, Lourdes Florensa and Carles Besses

      Accepted manuscript online: 1 AUG 2014 02:23AM EST | DOI: 10.1111/ejh.12425

    2. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukemia (CML) patients in chronic phase: Clinical results from a randomized phase 2 study (NordCML006)

      Henrik Hjorth-Hansen, Leif Stenke, Stina Söderlund, Arta Dreimane, Hans Ehrencrona, Tobias Gedde-Dahl, Bjørn Tore Gjertsen, Martin Höglund, Perttu Koskenvesa, Kourosh Lotfi, Waleed Majeed, Berit Markevärn, Lotta Ohm, Ulla Olsson-Strömberg, Kari Remes, Merja Suominen, Bengt Simonsson, Kimmo Porkka, Satu Mustjoki, Johan Richter and The Nordic CML Study Group (NCMLSG)

      Accepted manuscript online: 1 AUG 2014 02:23AM EST | DOI: 10.1111/ejh.12423

    3. HAUSP compartmentalization in Chronic Myeloid Leukemia

      Alessandro Morotti, Cristina Panuzzo, Sabrina Crivellaro, Giovanna Carrà, Angelo Guerrasio and Giuseppe Saglio

      Accepted manuscript online: 1 AUG 2014 02:21AM EST | DOI: 10.1111/ejh.12422

    4. Impact of pre-transplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation

      Sanjeet S. Dadwal, Bernard Tegtmeier, Xueli Liu, Paul Frankel, James Ito, Stephen J. Forman and Vinod Pullarkat

      Accepted manuscript online: 1 AUG 2014 02:21AM EST | DOI: 10.1111/ejh.12421

    5. Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α

      Caroline H. Riley, Morten Hansen, Marie K. Brimnes, Hans C. Hasselbalch, Ole W. Bjerrum, Per thor Straten, Inge Marie Svane and Morten Krogh Jensen

      Accepted manuscript online: 1 AUG 2014 02:20AM EST | DOI: 10.1111/ejh.12420

    6. Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?

      F Mattioli, M Puntoni, V Marini, C Fucile, G Milano, L Robbiano, S Perrotta, V. Pinto, A Martelli and G L Forni

      Accepted manuscript online: 1 AUG 2014 02:20AM EST | DOI: 10.1111/ejh.12419

    7. Long term results of a phase II trial with front-line concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma

      Hui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, Tsai-Yun Chen, Wu-Chou Su, Wen-Li Hwang, Jin-Ching Lin, Tzeon-Jye Chiou, Woei-Yao Kao, Chang-Fang Chiu, Yi-Fang Chang, Jeffrey S. Chang, Ming-Chih Chang and Ih-Jen Su

      Accepted manuscript online: 24 JUN 2014 12:38AM EST | DOI: 10.1111/ejh.12405

    8. Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high risk relapsed/refractory chronic lymphocytic leukemia patients

      Lucie Oberic, Willy Vaillant, Benjamin Hebraud, Christian Recher, Etienne Suc, Philippe Houyau, Guy Laurent and Loic Ysebaert

      Accepted manuscript online: 17 JUN 2014 10:03AM EST | DOI: 10.1111/ejh.12391

    9. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history

      N Gangat, EA Wassie, TL Lasho, C Finke, RP Ketterling, CA Hanson, A Pardanani, AP Wolanskyj, M Maffioli, R Casalone, F Passamonti and A Tefferi

      Accepted manuscript online: 3 JUN 2014 01:25AM EST | DOI: 10.1111/ejh.12389

    10. Role Of 18f-Fdg-Pet/Ct In The Management Of Burkitt Lymphoma

      Estrella Carrillo-Cruz, Víctor A Marín-Oyaga, María Solé Rodríguez, Isabel Borrego-Dorado, Fátima de la Cruz Vicente, Eduardo Quiroga Cantero, Marina Manzanares Pérez, Francisco J Capote, María J Ramírez Sánchez, Ildefonso Espigado Tocino, Herminia Pérez-Vega, Ricardo Vázquez-Albertino and Jose A Pérez-Simón

      Accepted manuscript online: 12 FEB 2014 11:47AM EST | DOI: 10.1111/ejh.12284

  11. Clinical Picture

    1. Massive Cystic Granulocytic Sarcoma In a Newly Diagnosed Patient with AML

      Emily A Graves and Paul A Cahalin

      Accepted manuscript online: 30 DEC 2011 08:50AM EST | DOI: 10.1111/j.1600-0609.2011.01749.x

  12. Original Articles

    1. A novel α0-thalassemia deletion in a Greek patient with HbH disease and β-thalassemia trait

      Marion Phylipsen, Jan Traeger-Synodinos, Martijn van der Kraan, Peter van Delft, Greet Bakker, Mariska Geerts, Emmanuel Kanavakis, Alexandra Stamoulakatou, Markissia Karagiorga, Piero C. Giordano and Cornelis L. Harteveld

      Accepted manuscript online: 30 DEC 2011 08:50AM EST | DOI: 10.1111/j.1600-0609.2011.01748.x

  13. Original Article

    1. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of Multiple Myeloma patients displaying short survival within the ISS stage I

      Gastinne Thomas, Leleu Xavier, Duhamel Alain, Moreau Anne-Sophie, Frank Genevieve, Andrieux Joris, Lai Jean-Luc, Coiteux Valerie, Yakoub-Agha Ibrahim, Bauters Francis, Harousseau Jean-Luc, Zandecki Marc, Facon Thierry and On behalf of the Intergroupe Francophone du Myelome (IFM).

      Article first published online: 28 JUN 2007 | DOI: 10.1111/j.1600-0609.2007.0915.x

  14. Case Reports

    1. Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures

      Carlos Fernández de Larrea, Laura Rosiñol, María Teresa Cibeira, María Rozman, Montserrat Rovira and Joan Bladé

      Accepted manuscript online: 23 JUL 2010 12:00AM EST | DOI: 10.1111/j.0902-4441.2010.01504.x


  1. 1 - 27